These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 2061640)

  • 41. A Case of neuroleptic malignant syndrome accompanied to an atypical antipsychotic agent: risperidone.
    Pasa S; Sayhan MB; Boyraz T; Urakci Z; Altintas A
    Neurotoxicology; 2008 Jul; 29(4):750-1. PubMed ID: 18539333
    [No Abstract]   [Full Text] [Related]  

  • 42. [Autopsied case of Parkinson disease with neuroleptic malignant-like syndrome and rhabdomyolysis].
    Akai M; Ishizaki T; Idemura Y; Sasaki F; Nakai T; Miyaho S; Matsubara R; Uchiki H; Nakaguki K
    Nihon Naika Gakkai Zasshi; 1992 Nov; 81(11):1863-4. PubMed ID: 1479229
    [No Abstract]   [Full Text] [Related]  

  • 43. Managing reboxetine-associated urinary hesitancy in a patient with major depressive disorder: a case study.
    Kasper S
    Psychopharmacology (Berl); 2002 Feb; 159(4):445-6. PubMed ID: 11823898
    [No Abstract]   [Full Text] [Related]  

  • 44. [Clinical differentiation between lethal catatonia and neuroleptic malignant syndrome: a case report].
    Terlikowska M; Marzański M
    Psychiatr Pol; 1995; 29(3):343-8. PubMed ID: 7652087
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reboxetine treatment and pseudopheochromocytoma.
    Zornitzki T; Knobler H; Schattner A
    QJM; 2007 Jan; 100(1):61-2. PubMed ID: 17175558
    [No Abstract]   [Full Text] [Related]  

  • 46. The neuroleptic malignant syndrome--a review.
    Gibb WR; Lees AJ
    Q J Med; 1985 Aug; 56(220):421-9. PubMed ID: 2864716
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Levodopa withdrawal and the neuroleptic malignant syndrome.
    Sandyk R; Iacono RP
    Postgrad Med J; 1986 Jul; 62(729):701-1. PubMed ID: 3748941
    [No Abstract]   [Full Text] [Related]  

  • 48. Neuroleptic malignant syndrome following tricyclic antidepressant overdose.
    Hund E; Wildemann B
    Intensive Care Med; 1997 Apr; 23(4):480-1. PubMed ID: 9142594
    [No Abstract]   [Full Text] [Related]  

  • 49. Neuroleptic malignant syndrome: impaired dopaminergic systems?
    Genís D
    Neurology; 1985 Dec; 35(12):1806. PubMed ID: 4069382
    [No Abstract]   [Full Text] [Related]  

  • 50. Asymptomatic reboxetine overdose.
    Bandinelli PL; Polselli GM
    Int J Neuropsychopharmacol; 2006 Apr; 9(2):257. PubMed ID: 15967062
    [No Abstract]   [Full Text] [Related]  

  • 51. Sufoxazine. Lucelan, Metatone, Teniloxazine, Y 8894.
    Drugs R D; 1999 Aug; 2(2):144-5. PubMed ID: 10820663
    [No Abstract]   [Full Text] [Related]  

  • 52. [Fever caused by medifoxamine].
    Guy C; Rousset H; Cartry O; Lauwers A; Ollagnier M
    Presse Med; 1996 Jan; 25(3):127. PubMed ID: 8746090
    [No Abstract]   [Full Text] [Related]  

  • 53. [Serotonin syndrome: critical review of the literature].
    Baubet T; Peronne E
    Rev Med Interne; 1997; 18(5):380-7. PubMed ID: 9183446
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Acute myopathy caused by psychotropic agents. Report of 2 cases].
    Romanelli R; Borghesi MR; Novaro G
    Pathologica; 1988; 80(1070):711-6. PubMed ID: 2907931
    [No Abstract]   [Full Text] [Related]  

  • 55. [Malignant syndromes due to psychotherapeutic agents].
    Chen YG
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1987 Dec; 20(6):332-3. PubMed ID: 2896110
    [No Abstract]   [Full Text] [Related]  

  • 56. [Neuroleptic malignant syndrome from treatment with antidepressives].
    Heinemann F; Assion HJ; Laux G
    Fortschr Neurol Psychiatr; 1997 May; 65(5):208-13. PubMed ID: 9235312
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Case of malignant syndrome suggesting a central hyperthermic mechanism].
    Yamamoto H; Kikuchi H; Ito H; Yamamoto A; Noda S
    Nihon Naika Gakkai Zasshi; 1991 Apr; 80(4):617-8. PubMed ID: 2061640
    [No Abstract]   [Full Text] [Related]  

  • 58. Fulminant liver failure due to neuroleptic malignant syndrome.
    Kesan SH; Sid R; Adler D; Crausman RS
    Med Health R I; 2000 May; 83(5):153-5. PubMed ID: 10874819
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.